Resources from the same session
1560O_PR - Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of cancer patients who recovered from SARS-CoV-2 infection
Presenter: Alessio Cortellini
Session: Proffered Paper session - SARS-CoV-2 and cancer
Resources:
Abstract
Slides
Webcast
1558O - COVID-19 vaccine in participants (ptcpts) with cancer: Subgroup analysis of efficacy/safety from a global phase III randomized trial of the BNT162b2 (tozinameran) mRNA vaccine
Presenter: Stephen Thomas
Session: Proffered Paper session - SARS-CoV-2 and cancer
Resources:
Abstract
Slides
Webcast
1559O - Efficacy and toxicity of BNT162b2 vaccine in cancer patients
Presenter: Ithai Waldhorn
Session: Proffered Paper session - SARS-CoV-2 and cancer
Resources:
Abstract
Slides
Webcast
1561O - The future of the oncology workforce since COVID-19: Results of the ESMO Resilience Task Force survey series
Presenter: Kok Haw Jonathan Lim
Session: Proffered Paper session - SARS-CoV-2 and cancer
Resources:
Abstract
Slides
Webcast
Q&A and live discussion
Presenter: Rebecca Lee
Session: Proffered Paper session - SARS-CoV-2 and cancer
Resources:
Slides
Webcast
Invited Discussant 1558O and 1559O
Presenter: Rebecca Lee
Session: Proffered Paper session - SARS-CoV-2 and cancer
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Anne-Marie Dingemans
Session: Proffered Paper session - SARS-CoV-2 and cancer
Resources:
Slides
Webcast